- ICH GCP
- 미국 임상 시험 레지스트리
- Search trials
Bionov가 후원하는 임상 시험
총 101 건
-
Kinnov TherapeuticsECSOR완전한
-
Anders Rasmussen Rinnov알려지지 않은
-
University of CopenhagenArla Foods; Hoeng Fonden; Bionor Pharma알려지지 않은
-
Beijing Tiantan HospitalBeijing Bionovo Medicine Development Co., Ltd.완전한
-
Oslo University HospitalEurocine Vaccines AB; Bionor Immuno AS완전한
-
Sebastiano BiondoHospital Universitari de Bellvitge모병
-
University of British ColumbiaBionic Power완전한
-
Biocon Biologics Inc.MEDA Pharma GmbH & Co. KG; Mylan Inc.; IQVIA Pvt. Ltd완전한
-
Jiangsu Kanion Pharmaceutical Co., LtdBeijing Bionovo Medicine Development Co., Ltd.완전한
-
Jiangsu Kanion Pharmaceutical Co., LtdBeijing Bionovo Medicine Development Co., Ltd.완전한
-
Jiangsu Kanion Pharmaceutical Co., LtdBeijing Bionovo Medicine Development Co., Ltd.알려지지 않은
-
Jiangsu Kanion Pharmaceutical Co., LtdBeijing Bionovo Medicine Development Co., Ltd.완전한
-
EquilliumBiocon Limited; Equillium AUS Pty Ltd완전한
-
Biocon LimitedProfil Institut für Stoffwechselforschung GmbH완전한
-
Guizhou Tongjitang Pharmaceutical Co.,LtdBeijing Bionovo Medicine Development Co., Ltd.알려지지 않은
-
Chongqing Fortune Pharmaceutical Co., Ltd.Beijing Bionovo Medicine Development Co., Ltd.완전한
-
Biocon LimitedProfil Institut für Stoffwechselforschung GmbH완전한
-
Jiangsu Kanion Pharmaceutical Co., LtdBeijing Bionovo Medicine Development Co., Ltd.완전한
-
Biocon LimitedProfil Institut für Stoffwechselforschung GmbH완전한
-
Biocon LimitedProfil Institut für Stoffwechselforschung GmbH완전한
-
Changchun Huayang High-tech Co., LtdBeijing Bionovo Medicine Development Co., Ltd.알려지지 않은
-
Sunnybrook Health Sciences CentreSeagen Inc.; Biocon Biologics모병
-
Shenzhen Ionova Life Sciences Co., Ltd.Merck Sharp & Dohme LLC모병암 | 고형 종양, 성인 | 고형암 | 고형 종양, 상세불명, 성인 | 암 전이 | 종양, 고형미국
-
Otto Bock Healthcare Products GmbHBionX Medical Technologies, Inc.완전한
-
Biocon LimitedJuvenile Diabetes Research Foundation; Profil Institut für Stoffwechselforschung GmbH종료됨
-
Swisse Wellness Pty LtdCommonwealth Scientific & Industrial Research Organisation; BIONAP SRL완전한
-
Bioinova, s.r.o.Department of Neurology, University Hospital Motol, Prague, Czech Republic종료됨
-
Bioinova, s.r.o.Department of Neurology, University Hospital Motol, Prague, Czech Republic완전한운동 신경 질환, 근위축성 측삭 경화증
-
Technovalia, Pty LtdChulalongkorn University; Southern Star Research Pty Ltd.; BioNet-Asia모집하지 않고 적극적으로
-
Bioinova, s.r.o.Department of Spine Surgery, University Hospital Motol, Prague, Czech Republilc종료됨
-
Francesco Bono모병
-
Pro Bono BioInternational Medical Research - Partner GmbH알려지지 않은
-
Cluster de Bioeconomia de Baja California, A.CBionag SAPI de CV; General Hospital Tijuana완전한
-
I.M. Sechenov First Moscow State Medical UniversityCentral Scientific Research Institute of Dentistry and Maxillo-facial Surgery, Moscow... 그리고 다른 협력자들완전한
-
University of SydneyTelethon Kids Institute; Bionet Co., Ltd; Technovalia; Institute for Clinical Pathology and...완전한
-
Spaulding Rehabilitation HospitalEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Bionic Skins LLC아직 모집하지 않음
-
Leiden University Medical CenterMedical Center Haaglanden; Rijnland Hospital; Groene Hart Ziekenhuis; Spaarne Gasthuis; Bronovo... 그리고 다른 협력자들완전한
-
St George's, University of LondonUniversity of British Columbia; Medical Research Council; Public Health England; MU-JHU CARE; BioNet-Asi...완전한
-
Center for Eye Research AustraliaAustralian National University; Commonwealth Scientific and Industrial Research Organisation... 그리고 다른 협력자들초대로 등록
-
Leiden University Medical CenterMedical Center Haaglanden; Groene Hart Ziekenhuis; Reinier de Graaf Groep; Haga Hospital; Alrijne... 그리고 다른 협력자들완전한
-
Mobius Medical Pty Ltd.University of Melbourne; Australian National University; Centre for Eye Research Australia; Bionics Institute 그리고 다른 협력자들완전한
-
Chulalongkorn UniversityBioNet-Asia; Chula Clinical Research Center (Chula CRC), Faculty of Medicine, Chulalongkorn... 그리고 다른 협력자들모병ChulaCov19-BNA159 mRNA 백신 25ug의 안전성 | ChulaCov19-BNA159 mRNA 백신 25ug의 내약성 | ChulaCov19-BNA159 mRNA 백신 25ug의 면역 반응 | ChulaCov19-BNA159 mRNA 백신 50ug의 안전성 | ChulaCov19-BNA159 mRNA 백신 50ug의 내약성 | ChulaCov19-BNA159 mRNA 백신 50ug의 면역 반응 | 어느 용량이 사용하기에 적합한지 평가태국
-
Arun Jayaraman, PT, PhDNorthwestern University; United States - India Science and Technology Endowment Fund; Induss... 그리고 다른 협력자들모집하지 않고 적극적으로
-
Amsterdam UMC, location VUmcUMC Utrecht; Dijklander Ziekenhuis; Medical Center Haaglanden; Elisabeth-TweeSteden Ziekenhuis 그리고 다른 협력자들완전한